Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key? Fabio AngeliGianpaolo Reboldi Commentary 19 June 2015 Pages: 221 - 224
Novel Targets of Drug Treatment for Pulmonary Hypertension Jian HuQinzi XuMark Gladwin Leading Article 28 May 2015 Pages: 225 - 234
Bleeding Risk, Management and Outcome in Patients Receiving Non-VKA Oral Anticoagulants (NOACs) Sebastian WerthTomás BreslinJan Beyer-Westendorf Review Article 05 May 2015 Pages: 235 - 242
Long-Term Anti-Hypertensive Therapy and Stroke Prevention: A Meta-Analysis Bertrand N. MuketeMark CassidyThierry H. Le Jemtel Review Article 09 June 2015 Pages: 243 - 257
Tolerability and Acceptability of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation: Systematic Review and Meta-Analysis Daniel CaldeiraNilza GonçalvesJoão Costa Systematic Review 20 June 2015 Pages: 259 - 265
The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing Scott E. KasnerLe WangStephen E. Kimmel Original Research Article 03 June 2015 Pages: 267 - 274
Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials Uzoma N. IbebuoguOluwaseyi BolorunduroGuy L. Reed Original Research Article 18 March 2015 Pages: 275 - 285
Erratum to: Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials Uzoma N. IbebuoguOluwaseyi BolorunduroGuy L. Reed Erratum 01 April 2015 Pages: 287 - 287
Blood Urea Nitrogen/Creatinine Ratio and Response to Tolvaptan in Patients with Decompensated Heart Failure: A Retrospective Analysis Dai OkayamaTsuyoshi SuzukiNobuhisa Hagiwara Short Communication 05 May 2015 Pages: 289 - 293
